lenalidomide has been researched along with Leukoencephalopathy, Progressive Multifocal in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Hamaguchi, T; Kamiya, KI; Komatsu, J; Nakamichi, K; Nakano, H; Saijo, M; Takano, S; Usui, Y; Yamada, M | 1 |
Barrio, S; Braggio, E; Collado, L; Folgueira, MD; Hernandez-Lain, A; Linares, M; Martinez-Lopez, J; Ramos, A; Rapado, I; Ruiz, J; Ruiz-Heredia, Y; Sanchez-Vega, B; Stewart, K; Toldos, O | 1 |
Anderson, S; Ho, PJ; Kiernan, M | 1 |
Brigo, F; Masi, E; Nardone, R; Pagani, E; Tezzon, F | 1 |
1 review(s) available for lenalidomide and Leukoencephalopathy, Progressive Multifocal
Article | Year |
---|---|
Lenalidomide-related Progressive Multifocal Leukoencephalopathy: A Case Report and Review of Drug-related Cases in Multiple Myeloma.
Topics: Cerebrospinal Fluid; Female; Humans; Immunologic Factors; Lenalidomide; Leukoencephalopathy, Progressive Multifocal; Maintenance Chemotherapy; Middle Aged; Multiple Myeloma; Stem Cell Transplantation | 2019 |
3 other study(ies) available for lenalidomide and Leukoencephalopathy, Progressive Multifocal
Article | Year |
---|---|
Progressive multifocal leukoencephalopathy during treatment with lenalidomide and elotuzumab for multiple myeloma.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Humans; Lenalidomide; Leukoencephalopathy, Progressive Multifocal; Multiple Myeloma | 2020 |
Concurrent progressive multifocal leukoencephalopathy and central nervous system infiltration by multiple myeloma: A case report.
Topics: Aged; Brain; Dexamethasone; Female; Humans; JC Virus; Lenalidomide; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Multiple Myeloma; Neoplasm Invasiveness | 2019 |
Lenalidomide-associated progressive multifocal leukoencephalopathy.
Topics: Humans; Lenalidomide; Leukoencephalopathy, Progressive Multifocal; Middle Aged; Multiple Myeloma; Prognosis | 2017 |